Thiabendazole Tablet, Suspension

17 April 2008

Products Affected - Description

Mintezol 500 mg chewable tablets, Merck
Mintezol 500 mg / 5 mL oral suspension, Merck

Reason for the Shortage

Merck discontinued thiabendazole oral suspension in April 2005 and thiabendazole chewable tablets in August 2006. There are no alternative manufacturers of thiabendazole.

Estimated Resupply Dates

Thiabendazole is discontinued.

Related Shortages

• Pentamidine Inhalation— Resolved
• Quinine Sulfate— Resolved
• Tetracycline Oral Liquid— No Longer Available
• Trimethoprim Tablets— Resolved
• Trimetrexate Injection— No Longer Available

Updated

April 17, 2008, University of Utah, Drug Information Service.

Back to Drug Shortage Product Bulletins